These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 15885353

  • 1. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [Abstract] [Full Text] [Related]

  • 2. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 3. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH, Kim YS, Jang JY, Cheon YG, Kim YS, Cho YD, Lee JS, Lee MS, Kim JH, Shim CS, Kim BS.
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [Abstract] [Full Text] [Related]

  • 4. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [Abstract] [Full Text] [Related]

  • 6. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

  • 7. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 8. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 9. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ, Chen HA, Lu MQ, Chen GH.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2065-9. PubMed ID: 19080277
    [Abstract] [Full Text] [Related]

  • 10. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov 20; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 11. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun 20; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 12. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb 20; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 13. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun 20; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 14. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 20; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.
    Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR.
    J Hepatol; 2004 Jun 20; 40(6):897-903. PubMed ID: 15158328
    [Abstract] [Full Text] [Related]

  • 17. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C.
    Clin Gastroenterol Hepatol; 2008 Nov 20; 6(11):1255-62. PubMed ID: 18995216
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    Korean J Hepatol; 2009 Sep 20; 15(3):350-6. PubMed ID: 19783884
    [Abstract] [Full Text] [Related]

  • 19. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM.
    Arch Surg; 2005 Jul 20; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [Abstract] [Full Text] [Related]

  • 20. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov 20; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.